tert-Butyl ((3R,5R)-5-(trifluoromethyl)piperidin-3-yl)carbamate

Catalog No. :
ACDSAP152
CAS No. :
1363378-12-4
Molecular Formula :
C11H19F3N2O2
Molecular Weight :
268.28

IUPAC Name:tert-butyl ((3R,5R)-5-(trifluoromethyl)piperidin-3-yl)carbamate

tert-Butyl ((3R,5R)-5-(trifluoromethyl)piperidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$923.00Login to see priceIn stockInquiry
250mg95%$1478.00Login to see priceIn stockInquiry
500mg95%$2462.00Login to see priceIn stockInquiry
1g95%$3690.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((3R,5R)-5-(trifluoromethyl)piperidin-3-yl)carbamate
IUPAC Nametert-butyl ((3R,5R)-5-(trifluoromethyl)piperidin-3-yl)carbamate
MDL No.MFCD22415262
Molecular FormulaC11H19F3N2O2
Molecular Weight268.28
SMILESO=C(OC(C)(C)C)N[C@H]1CNC[C@H](C(F)(F)F)C1
InChI KeyCUNVTZVWJLBPQS-HTQZYQBOSA-N
Synonymtert-butyl N-[trans-5-(trifluoromethyl)piperidin-3-yl]carbamate | CS-0057388 | DTXSID801125964 | CUNVTZVWJLBPQS-HTQZYQBOSA-N | AS-34506 | PB35632 | TERT-BUTYL N-[TRANS-5-(TRIFLUOROMETHYL)-3-PIPERIDYL]CARBAMATE | D79170 | tert-Butyl ((3R,5R)-5-(trifluorome
CAS No.1363378-12-4
PubChem CID72207739

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDSAP152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSAP152 route product structure diagram
    ACDSAP1521363378-12-4 In Stock
Inquiry

2. ACDSAP152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSAP152 route product structure diagram
    ACDSAP1521363378-12-4 In Stock
Inquiry

Comments (0)